Desensitization for solid organ and hematopoietic stem cell transplantation (Q26863564)

biomedical investigative technique

main subject

1 reference

19 September 2019

organ transplantation

1 reference

hematopoietic stem cell transplantation

25 November 2020

1 reference

3 July 2021

1 reference

Andrea A. Zachary

1

1 reference

Mary S. Leffell

series ordinal

2

1 reference

language of work or name

1 reference

March 2014

1 reference

1 March 2014

4 references

25 June 2019

19 September 2019

25 November 2020

3 July 2021

Immunological Reviews

5 references

25 June 2019

19 September 2019

25 November 2020

3 July 2021

258

1 reference

issue

1

1 reference

page(s)

183-207

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

copyright license

4 references

25 June 2019

19 September 2019

25 November 2020

Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation

3 July 2021

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children.

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Plasmapheresis adjusts inflammatory responses in potential kidney transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Alternative transplant donor sources: is there any consensus?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Successful experiences of ABO-incompatible adult living donor liver transplantation in a single institute: no immunological failure in 10 consecutive cases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société França

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

On the role of HLA antibodies in hematopoietic stem cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Genetics of graft-versus-host disease: the major histocompatibility complex

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Improving outcomes in umbilical cord blood transplantation: state of the art.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Pushing the boundaries: the current status of ABO-incompatible cardiac transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Impact of HLA matching and HLA antibodies in organ transplantation: a collaborative transplant study view

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Emerging concepts in haematopoietic cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Outcomes of ABO-incompatible kidney transplantation in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

The role of HLA antibodies in allogeneic SCT: is the 'type-and-screen' strategy necessary not only for blood type but also for HLA?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Immune regulatory function of B cells.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

How to deal with presensitized candidates for heart transplantation?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

The role of anti-HLA antibodies in hematopoietic stem cell transplantation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Anti-HLA antibodies in double umbilical cord blood transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Management of ABO-incompatible living-donor liver transplantation: past and present trends

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Allogeneic hematopoietic cell transplantation: the state of the art

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Non-MHC antigenic targets of the humoral immune response in transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Isoagglutinin adsorption in ABO-incompatible transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

ABO-incompatible kidney transplantation: current practice and the decade ahead

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Incidence of humoral sensitization in HLA partially mismatched hematopoietic stem cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Intravenous immunoglobulin therapy for autoimmune diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

ABO incompatible renal transplantation: a paradigm ready for broad implementation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Japanese experience of ABO-incompatible living kidney transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Graft failure after allogeneic hematopoietic cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

14th International HLA and Immunogenetics Workshop: report on understanding antibodies in transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

B-cell tolerance following ABO-incompatible infant heart transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Targeting antibody-mediated rejection in the setting of ABO-incompatible infant heart transplantation: graft accommodation vs. B cell tolerance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Current approaches to treatment of antibody-mediated rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

ABO-incompatibility in solid organ transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

ABO blood group incompatible kidney transplantation: a case report and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Rituximab prevents an anamnestic response in patients with cryptic sensitization to HLA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

B-cell-dependent memory T cells impede nonmyeloablative mixed chimerism induction in presensitized mice

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Treatment of acute antibody-mediated rejection: a single-center experience

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Epitope analysis of HLA class I donor specific antibodies in sensitized renal transplant recipients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

The frequencies of HLA alleles and haplotypes and their distribution among donors and renal patients in the UNOS registry

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Outcome of renal transplantation following a positive cross-match with historical sera: the ASHI survey.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Antibody-mediated marrow failure after allogeneic bone marrow transplantation.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

The occurrence of cytotoxic and non-complement-fixing antibodies in the crossmatch serum of patients with early acute rejection episodes

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

The association between a positive T and B cell flow cytometry crossmatch and renal transplant failure

31 May 2018

1 reference

Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy

21 January 2018

1 reference

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients

21 January 2018

1 reference

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

21 January 2018

1 reference

Desensitizing the broadly human leukocyte antigen-sensitized patient awaiting deceased donor kidney transplantation

21 January 2018

1 reference

Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients.

21 January 2018

1 reference

Reply to "Defining the benefits of desensitization therapy".

21 January 2018

1 reference

Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience

21 January 2018

1 reference

21 January 2018

1 reference

Intravenous immunoglobulin: a safe option for treatment of steroid-resistant rejection in the presence of infection.

21 January 2018

1 reference

High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis

21 January 2018

1 reference

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin.

21 January 2018

1 reference

Overcoming a positive crossmatch in living-donor kidney transplantation.

21 January 2018

1 reference

Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation

21 January 2018

1 reference

Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of the renal allograft: a single-center experience

21 January 2018

1 reference

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

21 January 2018

1 reference

Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients

21 January 2018

1 reference

Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production

21 January 2018

1 reference

Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.

21 January 2018

1 reference

HLA-specific B cells: II. Application to transplantation.

21 January 2018

1 reference

Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.

21 January 2018

1 reference

Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients

21 January 2018

1 reference

Five-year outcomes in living donor kidney transplants with a positive crossmatch.

21 January 2018

1 reference

Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience

21 January 2018

1 reference

Desensitization in HLA-incompatible kidney recipients and survival.

21 January 2018

1 reference

Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy

21 January 2018

1 reference

Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.

21 January 2018

1 reference

Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations

21 January 2018

1 reference

The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction

21 January 2018

1 reference

Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors

21 January 2018

1 reference

ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation.

21 January 2018

1 reference

HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway

21 January 2018

1 reference

Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+Foxp3+ T cells

21 January 2018

1 reference

Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction

21 January 2018

1 reference

Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells.

21 January 2018

1 reference

Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen

21 January 2018

1 reference

Accommodation in ABO-incompatible kidney transplantation: why do kidney grafts survive?

21 January 2018

1 reference

The impact of anti-HLA antibodies on unrelated cord blood transplantations.

21 January 2018

1 reference

Rapid hematopoietic recovery with high levels of DSA in an unmanipulated haploidentical transplant patient.

21 January 2018

1 reference

Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

21 January 2018

1 reference

Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source

21 January 2018

1 reference

Clinical significance of recipient antibodies to stem cell donor mismatched class I HLA antigens.

21 January 2018

1 reference

Differing mechanisms of early and late B cell hyporesponsiveness induced by mixed chimerism

21 January 2018

1 reference

The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

National Organ Transplant Act: Public Law 98-507.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237559

Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: a case report

28 November 2018

1 reference

12 December 2020

Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients

1 reference

12 December 2020

Successful transplantation of highly selected CD34+ peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto protein A

1 reference

12 December 2020

Elimination of alloantibodies by immunoablative high-dose cyclophosphamide

1 reference

12 December 2020

Kidney graft failure and presensitization against HLA class I and class II antigens

1 reference

12 December 2020

Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation

1 reference

12 December 2020

Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)

1 reference

12 December 2020

Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients

1 reference

12 December 2020

Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway

1 reference

12 December 2020

Renal transplantation in patients with lymphocytotoxic antibodies--a 5-year experience from a single centre

1 reference

12 December 2020

Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching

1 reference

12 December 2020

Transplanting patients with a positive donor-specific crossmatch: a single center's perspective

1 reference

12 December 2020

Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion

1 reference

12 December 2020

A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation

1 reference

12 December 2020

IVIG vs. plasmapheresis for desensitization: which is better?

1 reference

12 December 2020

A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs

1 reference

12 December 2020

HLA-specific B cells: I. A method for their detection, quantification, and isolation using HLA tetramers

1 reference

12 December 2020

Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation

1 reference

12 December 2020

Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab

1 reference

12 December 2020

Sensitization in renal transplantation

1 reference

12 December 2020

Antibody-mediated rejection in heart transplant recipients: potential efficacy of B-cell depletion and antibody removal

1 reference

12 December 2020

Rescue splenectomy for severe acute antibody-mediated rejection

1 reference

12 December 2020

Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients

1 reference

12 December 2020

AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival

1 reference

12 December 2020

Significance of HLA class I antibody-induced antioxidant gene expression for endothelial cell protection against complement attack

1 reference

12 December 2020

Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation

1 reference

12 December 2020

Overcoming HLA-DPB1 donor specific antibody-mediated haematopoietic graft failure

1 reference

12 December 2020

Donor-HLA-incompatible marrow transplantation with an anti-donor cytotoxic antibody in the serum of the patient

1 reference

12 December 2020

The flow cytometric crossmatch and early renal transplant loss

1 reference

12 December 2020

Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation

1 reference

12 December 2020

Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT

1 reference

12 December 2020

Limitations of rituximab/IVIg desensitization protocol in kidney transplantation; is this better than a tincture of time?

1 reference

12 December 2020

Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients

1 reference

12 December 2020

Humoral HLA sensitization matters in CBT outcome

1 reference

12 December 2020

Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody

1 reference

12 December 2020

Excellent outcomes of ABO-incompatible kidney transplantation: a single-center experience

1 reference

12 December 2020

Proteasome inhibition by bortezomib: effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation

1 reference

12 December 2020

Extracorporeal removal of anti-HLA antibodies in transplant candidates

1 reference

12 December 2020

HLA antibody detection and characterization by solid phase immunoassays: methods and pitfalls

1 reference

12 December 2020

Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection

1 reference

12 December 2020

Role of apheresis and dialysis in pediatric living donor liver transplantation: a single center retrospective study

1 reference

12 December 2020

ABO-incompatible kidney transplantation

1 reference

12 December 2020

A decrease in the percentage of CD3+ cells is correlated with clinical improvement during plasmapheresis in patients with myasthenia gravis

1 reference

12 December 2020

Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab

1 reference

12 December 2020

Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation

1 reference

12 December 2020

Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome

1 reference

12 December 2020

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma

1 reference

12 December 2020

Graft outcome in the multiple transplant patient with a positive donor cross-match with non-current sera

1 reference

12 December 2020

Liver transplantation across ABO blood groups

1 reference

12 December 2020

Calculation of a predictive value for transplantation

1 reference

12 December 2020

The effect of plasmapheresis and drug immunosuppression on T-cell subsets as defined by monoclonal antibodies

1 reference

12 December 2020

Plasma exchange and immunoadsorption for removal of antibodies prior to ABO incompatible bone marrow transplant

1 reference

12 December 2020

Beneficial effects of double-filtration plasmapheresis on living related donor renal transplantation in presensitized recipients

1 reference

12 December 2020

Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients

1 reference

12 December 2020

Plasmapheresis in HLA-immunosensitized patients prior to kidney transplantation

1 reference

12 December 2020

Determinant spreading: lessons from animal models and human disease

1 reference

12 December 2020

Identifiers

DOI

10.1111/IMR.12150

1 reference

1497792

1497792

1 reference

1 reference

1 reference